drugset / Trial / NCT00431145

Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)

NCT00431145

Phase 2 Unknown 80 enrolled Ludwig-Maximilians - University of Munich
RandomizedParallel-groupOpen-labelTreatment

Summary

Aim of the study is to show additional effects of the combined therapy of niacin and statins analyzing number and function of EPCs and other stem cell populations and adiponectin as well as hsCRP levels in patients with CAD.

Timeline

Start
2006-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule